Patients at risk of onychomycosis -: risk factor identification and active prevention

被引:77
|
作者
Tosti, A
Hay, R
Arenas-Guzmán, R
机构
[1] Univ Bologna, I-40124 Bologna, Italy
[2] Queens Univ Belfast, Fac Med & Hlth Sci, Belfast BT9 7BL, Antrim, North Ireland
关键词
onychomycosis; prevention; recurrence; risk factors;
D O I
10.1111/j.1468-3083.2005.01282.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objectives The aims of this workshop were to identify risk factors for onychomycosis and to reach consensus on the management of high-risk groups to allow the development of guidelines to help doctors recognize risk factors that complicate treatment. Results and Conclusions Previous Trichophyton rubrum infection, older age, abnormal nail morphology, immunodeficiency and genetic factors were identified as risk factors for initial infections. Risk factors for recurrence (relapse and re-infection) are largely the same. The experts agreed that the prevention of onychomycosis and its recurrence should be based on the correct treatment of tinea pedis, screening family members and adequate patient education. In addition, generic management recommendations for each high-risk group were discussed: Immunosuppressed patients Usual dose and treatment length not appropriate Follow-up required Beware of drug interactions Diabetics Prophylactic foot care combined with nail treatment Good opportunity for patient education, footwear, foot care, etc. Beware of drug interactions Psoriatics and patients with abnormal nails Dermatophyte eradication does not restore normal nails Children High failure rate possibly due to compliance problems.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 50 条
  • [1] Epidemiology of onychomycosis in Italy: prevalence data and risk factor identification
    Papini, Manuela
    Piraccini, Bianca Maria
    Difonzo, Elisa
    Brunoro, Andrea
    MYCOSES, 2015, 58 (11) : 659 - 664
  • [2] Allergic disease prevention and risk factor identification
    Lasley, MV
    IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 1999, 19 (01) : 149 - +
  • [3] Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification
    Dubljanin, E. S.
    Dzamic, A. M.
    Vujcic, I. S.
    Grujicic, S. S.
    Arsic-Arsenijevic, V.
    Mitrovic, S.
    Calovski, I. C.
    MYCOSES, 2017, 60 : 228 - 228
  • [4] Epidemiology of onychomycosis in Serbia: a laboratory-based survey and risk factor identification
    Dubljanin, Eleonora
    Dzamic, Aleksandar
    Vujcic, Isidora
    Grujicic, Sandra S.
    Arsenijevic, Valentina A.
    Mitrovic, Sanja
    Calovski, Ivana Colovic
    MYCOSES, 2017, 60 (01) : 25 - 32
  • [5] Is slow nail growth a risk factor for onychomycosis?
    Yu, HJ
    Kwon, HM
    Oh, DH
    Kim, JS
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2004, 29 (04) : 415 - 418
  • [6] Pneumonia in patients with stroke: risk factors, identification of at-risk patients, and methods of prevention
    Turlakiewicz, Michal
    Piekarska, Anna
    AKTUALNOSCI NEUROLOGICZNE, 2020, 20 (02): : 88 - 96
  • [7] The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients
    Kuvandik, Gueven
    Cetin, Meryem
    Genctoy, Gultekin
    Horoz, Mehmet
    Duru, Mehmet
    Akcali, Cenk
    Satar, Salim
    Kiykim, Ahmet A.
    Kaya, Hasan
    BMC INFECTIOUS DISEASES, 2007, 7 (1)
  • [8] SECONDARY PREVENTION ATHEROSCLEROSIS - EMPHASIZING RISK FACTOR MANAGEMENT TO PATIENTS
    HIRATZKA, LF
    ANNALS OF THORACIC SURGERY, 1995, 60 (01): : 1 - 1
  • [9] The prevalance, epidemiology and risk factors for onychomycosis in hemodialysis patients
    Güven Kuvandik
    Meryem Çetin
    Gultekin Genctoy
    Mehmet Horoz
    Mehmet Duru
    Cenk Akcali
    Salim Satar
    Ahmet A Kiykim
    Hasan Kaya
    BMC Infectious Diseases, 7
  • [10] Identification of patients for clinical risk assessment by prediction of cardiovascular risk using default risk factor values
    Marshall, Tom
    BMC PUBLIC HEALTH, 2008, 8 (1)